NKTR
Nektar Therapeutics
Price:  
1.01 
USD
Volume:  
2,057,610.00
United States | Pharmaceuticals
Valuation
Overview
Financials
Forecast
Compare
Historical Price
SolvencyDividends
Transactions
People

NKTR Relative Valuation

-2308.7%
Upside

As of 2024-12-15, the Relative Valuation of Nektar Therapeutics (NKTR) is (22.31) USD. This relative valuation is based on P/E multiples. With the latest stock price at 1.01 USD, the upside of Nektar Therapeutics based on Relative Valuation is -2308.7%.

The range of the Relative Valuation is (15.82) - (24.74) USD.

Note: valuation result may not be accurate due to the company's negative earnings.

Range Selected
Trailing P/E multiples 17.3x - 27.1x 24.0x
Forward P/E multiples 17.3x - 27.5x 24.9x
Fair Price (15.82) - (24.74) (22.31)
Upside -1666.4% - -2549.9% -2308.7%
1.01 USD
Stock Price
(22.31) USD
Fair Price

NKTR Relative Valuation - Historical P/E Data

Date P/E
2024-12-04 -1.12
2024-12-03 -1.17
2024-12-02 -1.29
2024-11-29 -1.25
2024-11-27 -1.24
2024-11-26 -1.17
2024-11-25 -1.19
2024-11-22 -1.15
2024-11-21 -1.11
2024-11-20 -1.10
2024-11-19 -1.13
2024-11-18 -1.13
2024-11-15 -1.17
2024-11-14 -1.28
2024-11-13 -1.40
2024-11-12 -1.44
2024-11-11 -1.50
2024-11-08 -1.53
2024-11-07 -1.50
2024-11-06 -1.52
2024-11-05 -1.53
2024-11-04 -1.46
2024-11-01 -1.35
2024-10-31 -1.30
2024-10-30 -1.37
2024-10-29 -1.39
2024-10-28 -1.49
2024-10-25 -1.45
2024-10-24 -1.48
2024-10-23 -1.55
2024-10-22 -1.58
2024-10-21 -1.52
2024-10-18 -1.55
2024-10-17 -1.59
2024-10-16 -1.51
2024-10-15 -1.41
2024-10-14 -1.45
2024-10-11 -1.49
2024-10-10 -1.41
2024-10-09 -1.42
2024-10-08 -1.42
2024-10-07 -1.40
2024-10-04 -1.45
2024-10-03 -1.42
2024-10-02 -1.46
2024-10-01 -1.42
2024-09-30 -1.42
2024-09-27 -1.28
2024-09-26 -1.22
2024-09-25 -1.27